These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 1353403)
21. Characterization of the inhibition of excitatory amino acid-induced neurotransmitter release in the rat striatum by phencyclidine-like drugs. Snell LD; Johnson KM J Pharmacol Exp Ther; 1986 Sep; 238(3):938-46. PubMed ID: 2875174 [TBL] [Abstract][Full Text] [Related]
22. N-methyl-D-aspartate receptors mediating hippocampal noradrenaline and striatal dopamine release display differential sensitivity to quinolinic acid, the HIV-1 envelope protein gp120, external pH and protein kinase C inhibition. Pittaluga A; Pattarini R; Feligioni M; Raiteri M J Neurochem; 2001 Jan; 76(1):139-48. PubMed ID: 11145986 [TBL] [Abstract][Full Text] [Related]
23. Heterogeneity of N-methyl-D-aspartate receptors regulating the release of dopamine and acetylcholine from striatal slices. Cai NS; Kiss B; Erdö SL J Neurochem; 1991 Dec; 57(6):2148-51. PubMed ID: 1834803 [TBL] [Abstract][Full Text] [Related]
24. Mediation of glutamatergic receptors and nitric oxide on striatal dopamine release evoked by anatoxin-a. An in vivo microdialysis study. Campos F; Alfonso M; Vidal L; Faro LR; Durán R Eur J Pharmacol; 2006 Oct; 548(1-3):90-8. PubMed ID: 16963020 [TBL] [Abstract][Full Text] [Related]
26. Dopamine enhancement of NMDA currents in dissociated medium-sized striatal neurons: role of D1 receptors and DARPP-32. Flores-Hernández J; Cepeda C; Hernández-Echeagaray E; Calvert CR; Jokel ES; Fienberg AA; Greengard P; Levine MS J Neurophysiol; 2002 Dec; 88(6):3010-20. PubMed ID: 12466426 [TBL] [Abstract][Full Text] [Related]
27. Changes in the striatal extracellular levels of dopamine and dihydroxyphenylacetic acid evoked by ammonia and N-methyl-D-aspartate: modulation by taurine. Anderzhanova E; Oja SS; Saransaari P; Albrecht J Brain Res; 2003 Jul; 977(2):290-3. PubMed ID: 12834890 [TBL] [Abstract][Full Text] [Related]
28. A further evaluation of the effects of K+ depolarization on glutamate-evoked [3H]dopamine release from striatal slices. Bowyer JF; Newport GD; Lipe GW; Frame LT J Pharmacol Exp Ther; 1992 Apr; 261(1):72-80. PubMed ID: 1348539 [TBL] [Abstract][Full Text] [Related]
29. The NR2B-selective N-methyl-D-aspartate receptor antagonist Ro 25-6981 [(+/-)-(R*,S*)-alpha-(4-hydroxyphenyl)-beta-methyl-4-(phenylmethyl)-1-piperidine propanol] potentiates the effect of nicotine on locomotor activity and dopamine release in the nucleus accumbens. Kosowski AR; Liljequist S J Pharmacol Exp Ther; 2004 Nov; 311(2):560-7. PubMed ID: 15256539 [TBL] [Abstract][Full Text] [Related]
30. Intrastriatal infusion of (+/-)-S-nitroso-N-acetylpenicillamine releases vesicular dopamine via an ionotropic glutamate receptor-mediated mechanism: an in vivo microdialysis study in chloral hydrate-anesthetized rats. West AR; Galloway MP J Neurochem; 1996 May; 66(5):1971-80. PubMed ID: 8780025 [TBL] [Abstract][Full Text] [Related]
31. Electrophysiological evidence that intrastriatally administered N-methyl-D-aspartate augments striatal dopamine tone in the rat. Overton P; Clark D J Neural Transm Park Dis Dement Sect; 1992; 4(1):1-14. PubMed ID: 1540303 [TBL] [Abstract][Full Text] [Related]
32. The release of dopamine from nerve terminals and dendrites of nigrostriatal neurons induced by excitatory amino acids in the conscious rat. Westerink BH; Santiago M; De Vries JB Naunyn Schmiedebergs Arch Pharmacol; 1992 May; 345(5):523-9. PubMed ID: 1528270 [TBL] [Abstract][Full Text] [Related]
33. Differential effects of M1- and M2-muscarinic drugs on striatal dopamine release and metabolism in freely moving rats. Xu M; Mizobe F; Yamamoto T; Kato T Brain Res; 1989 Aug; 495(2):232-42. PubMed ID: 2765928 [TBL] [Abstract][Full Text] [Related]
34. Modulation of striatal dopamine release by glycine transport inhibitors. Javitt DC; Hashim A; Sershen H Neuropsychopharmacology; 2005 Apr; 30(4):649-56. PubMed ID: 15688094 [TBL] [Abstract][Full Text] [Related]
35. Progesterone in vitro increases NMDA-evoked [3H] dopamine release from striatal slices in proestrus rats. Cabrera RJ; Navarro CE Neuropharmacology; 1996 Feb; 35(2):175-8. PubMed ID: 8734486 [TBL] [Abstract][Full Text] [Related]
36. Glutamatergic control of dopamine release in the rat striatum: evidence for presynaptic N-methyl-D-aspartate receptors on dopaminergic nerve terminals. Krebs MO; Desce JM; Kemel ML; Gauchy C; Godeheu G; Cheramy A; Glowinski J J Neurochem; 1991 Jan; 56(1):81-5. PubMed ID: 1824785 [TBL] [Abstract][Full Text] [Related]
37. NMDA receptors with different sensitivities to magnesium and ifenprodil control the release of [14C]acetylcholine and [3H]spermidine from rat striatal slices in vitro. Nicolas C; Fage D; Carter C J Neurochem; 1994 May; 62(5):1835-9. PubMed ID: 7908945 [TBL] [Abstract][Full Text] [Related]
38. Potentiation of N-methyl-D-aspartate-stimulated dopamine release from rat brain slices by aluminum fluoride and carbachol. Woodward JJ; Harms J J Neurochem; 1992 Apr; 58(4):1547-54. PubMed ID: 1532197 [TBL] [Abstract][Full Text] [Related]
39. Systemic nicotine stimulates dopamine release in nucleus accumbens: re-evaluation of the role of N-methyl-D-aspartate receptors in the ventral tegmental area. Fu Y; Matta SG; Gao W; Brower VG; Sharp BM J Pharmacol Exp Ther; 2000 Aug; 294(2):458-65. PubMed ID: 10900219 [TBL] [Abstract][Full Text] [Related]
40. D1 dopamine receptor-mediated induction of zif268 and c-fos in the dopamine-depleted striatum: differential regulation and independence from NMDA receptors. Keefe KA; Gerfen CR J Comp Neurol; 1996 Apr; 367(2):165-76. PubMed ID: 8708002 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]